• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解间质性肺疾病患者慢性咳嗽的体验。

Understanding patient experience of chronic cough in interstitial lung disease.

作者信息

Mann Jennifer M V, Holland Anne E, Goh Nicole S L, Khor Yet H

机构信息

Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Australia.

The Institute for Breathing and Sleep, Melbourne, Australia.

出版信息

ERJ Open Res. 2023 May 22;9(3). doi: 10.1183/23120541.00039-2023. eCollection 2023 May.

DOI:10.1183/23120541.00039-2023
PMID:37228271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10204822/
Abstract

RATIONALE

Chronic cough is a common symptom in patients with interstitial lung disease (ILD), negatively contributing to health-related quality of life. Despite this, there is limited information and understanding on the experience of this group of patients with chronic cough. This study aimed to explore the symptom experiences for chronic cough in patients with ILD to identify its characteristics and impacts.

METHODS

A qualitative study using semi-structured telephone interviews was undertaken in 16 adults with a diagnosis of ILD of any type and severity. Patients were recruited from a quaternary referral centre in Melbourne, Australia. Interviews were transcribed verbatim and coded by two researchers using thematic analysis.

RESULTS

Patients (age range: 39-87 years, forced vital capacity: 53-107% predicted and diffusing capacity of the lung for carbon monoxide: 28-89% predicted) experienced a spectrum of cough severity and characteristics, including both dry and productive coughs. The impact of chronic cough included physical symptoms, social and emotional difficulties, and interference with work and vocational participation. Management strategies used to relieve cough included mucolytics, opiates, throat lozenges, warm drinks, pacing, breath control, relaxation exercises, movement, continuous positive airways pressure and supplemental oxygen. Patients expressed a need for further information and education regarding chronic cough, including its triggers and management.

CONCLUSIONS

This study highlights the experience and significance of chronic cough in patients with ILD. The nature and severity of chronic cough in patients with ILD appears to be more heterogeneous than previously described, with physical, social and emotional impacts contributing to symptom burden.

摘要

原理

慢性咳嗽是间质性肺疾病(ILD)患者的常见症状,对健康相关生活质量有负面影响。尽管如此,对于这组慢性咳嗽患者的经历,相关信息和了解却很有限。本研究旨在探讨ILD患者慢性咳嗽的症状体验,以确定其特征和影响。

方法

采用半结构式电话访谈对16名诊断为任何类型和严重程度ILD的成年人进行了定性研究。患者从澳大利亚墨尔本的一家四级转诊中心招募。访谈逐字记录,并由两名研究人员使用主题分析法进行编码。

结果

患者(年龄范围:39 - 87岁,用力肺活量:预测值的53 - 107%,肺一氧化碳弥散量:预测值的28 - 89%)经历了一系列咳嗽严重程度和特征,包括干咳和咳痰。慢性咳嗽的影响包括身体症状、社交和情感困难,以及对工作和职业参与的干扰。用于缓解咳嗽的管理策略包括黏液溶解剂、阿片类药物、含片、热饮、调整节奏、呼吸控制、放松练习、运动、持续气道正压通气和补充氧气。患者表示需要关于慢性咳嗽的更多信息和教育,包括其触发因素和管理方法。

结论

本研究强调了ILD患者慢性咳嗽的体验和重要性。ILD患者慢性咳嗽的性质和严重程度似乎比先前描述的更加异质性,身体、社交和情感方面的影响加重了症状负担。

相似文献

1
Understanding patient experience of chronic cough in interstitial lung disease.了解间质性肺疾病患者慢性咳嗽的体验。
ERJ Open Res. 2023 May 22;9(3). doi: 10.1183/23120541.00039-2023. eCollection 2023 May.
2
Understanding cough in interstitial lung disease: a cross-sectional study on the adequacy of treatment.理解间质性肺疾病中的咳嗽:一项关于治疗充分性的横断面研究。
Intern Med J. 2021 Jun;51(6):923-929. doi: 10.1111/imj.14837.
3
Symptoms and disease severity in lung transplant candidates co-managed with palliative care.肺移植候选者与姑息治疗共同管理的症状和疾病严重程度。
Ann Palliat Med. 2023 Mar;12(2):324-335. doi: 10.21037/apm-22-905.
4
Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.患者对难治性或不明原因的慢性咳嗽的体验:定性分析。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241236025. doi: 10.1177/17534666241236025.
5
Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.与其他纤维性间质性肺疾病相比,系统性硬化症相关间质性肺疾病患者的咳嗽症状较少见且程度较轻。
Respirology. 2017 Nov;22(8):1592-1597. doi: 10.1111/resp.13084. Epub 2017 May 23.
6
Clinical significance of self-reported cough intensity and frequency in patients with interstitial lung disease: a cross-sectional study.特发性肺纤维化患者自我报告咳嗽强度和频率的临床意义:一项横断面研究。
BMC Pulm Med. 2019 Dec 16;19(1):247. doi: 10.1186/s12890-019-1012-6.
7
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
8
Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease.患有间质性肺病的进行性系统性硬化症患者咳嗽反射敏感性增加。
Eur Respir J. 1998 Mar;11(3):702-5.
9
Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study.硬皮病相关性间质性肺病咳嗽与疾病活动度及环磷酰胺治疗的相关性:硬皮病肺研究的结果。
Chest. 2012 Sep;142(3):614-621. doi: 10.1378/chest.11-0801.
10
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.吡非尼酮治疗无法分类的进行性纤维化间质性肺疾病患者:一项双盲、随机、安慰剂对照、2 期临床试验。
Lancet Respir Med. 2020 Feb;8(2):147-157. doi: 10.1016/S2213-2600(19)30341-8. Epub 2019 Sep 29.

引用本文的文献

1
Patient-reported outcome measures for cough used in interstitial lung disease: a systematic review.间质性肺疾病中使用的咳嗽患者报告结局指标:一项系统评价。
Eur Respir Rev. 2025 Jul 9;34(177). doi: 10.1183/16000617.0206-2024. Print 2025 Jul.
2
Updates on the Prevalence, Quality of Life, and Management of Chronic Cough in Interstitial Lung Diseases.间质性肺疾病中慢性咳嗽的患病率、生活质量及管理的最新进展
Diagnostics (Basel). 2025 Apr 29;15(9):1139. doi: 10.3390/diagnostics15091139.
3
Living with chronic cough: experiences, burden and management in interstitial lung disease - a mixed methods study.间质性肺疾病患者慢性咳嗽的生活体验、负担及管理——一项混合方法研究
ERJ Open Res. 2025 Feb 25;11(1). doi: 10.1183/23120541.00641-2024. eCollection 2025 Jan.
4
Examining Cough's Role and Relief Strategies in Interstitial Lung Disease.探讨咳嗽在间质性肺疾病中的作用及缓解策略。
J Clin Med. 2025 Jan 6;14(1):291. doi: 10.3390/jcm14010291.
5
Anchoring Patient Voices to Shape the Future of Patient-reported Outcomes.锚定患者声音,塑造患者报告结局的未来。
Ann Am Thorac Soc. 2024 Dec;21(12):1651-1652. doi: 10.1513/AnnalsATS.202410-1028ED.
6
Evidence-based management of symptoms in serious respiratory illness: what is in our toolbox?重症呼吸系统疾病症状的循证管理:我们的工具箱里有什么?
Eur Respir Rev. 2024 Oct 30;33(174). doi: 10.1183/16000617.0205-2024. Print 2024 Oct.
7
Objective measurement of cough in pulmonary fibrosis: a cohort study - ImpaCT.肺纤维化中咳嗽的客观测量:一项队列研究——ImpaCT
ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.00310-2024. eCollection 2024 Sep.
8
Assessing health-related quality of life in patients with interstitial lung diseases.评估间质性肺疾病患者的健康相关生活质量。
BMC Pulm Med. 2024 Sep 13;24(1):452. doi: 10.1186/s12890-024-03262-9.
9
Research priorities for progressive pulmonary fibrosis in the UK.英国进行性肺纤维化研究重点。
BMJ Open Respir Res. 2024 Sep 3;11(1):e002368. doi: 10.1136/bmjresp-2024-002368.
10
The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis.特发性肺纤维化和其他间质性肺疾病咳嗽负担:系统证据综合。
Respir Res. 2024 Aug 27;25(1):325. doi: 10.1186/s12931-024-02897-w.

本文引用的文献

1
Cough in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中的咳嗽
Front Rehabil Sci. 2021 Oct 18;2:751798. doi: 10.3389/fresc.2021.751798. eCollection 2021.
2
Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel.评估难治性或不明原因慢性咳嗽的咳嗽症状严重程度:来自患者焦点小组和国际专家小组的研究结果
ERJ Open Res. 2022 Mar 14;8(1). doi: 10.1183/23120541.00667-2021. eCollection 2022 Jan.
3
The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review.特发性肺纤维化患者及其照护者的支持性护理需求:系统评价。
Eur Respir Rev. 2020 Apr 29;29(156). doi: 10.1183/16000617.0125-2019. Print 2020 Jun 30.
4
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.ERS 指南:成人和儿童慢性咳嗽的诊断与治疗。
Eur Respir J. 2020 Jan 2;55(1). doi: 10.1183/13993003.01136-2019. Print 2020 Jan.
5
Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel Report.特发性肺纤维化相关咳嗽的治疗:CHEST 指南和专家小组报告。
Chest. 2018 Oct;154(4):904-917. doi: 10.1016/j.chest.2018.06.038. Epub 2018 Jul 20.
6
Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review.纤维化间质性肺疾病患者的症状患病率:系统文献回顾。
BMC Pulm Med. 2018 May 22;18(1):78. doi: 10.1186/s12890-018-0651-3.
7
Determinants and outcomes of prolonged anxiety and depression in idiopathic pulmonary fibrosis.特发性肺纤维化中持续性焦虑和抑郁的决定因素及结局
Eur Respir J. 2017 Aug 17;50(2). doi: 10.1183/13993003.00168-2017. Print 2017 Aug.
8
'Chronic cough, cause unknown': A qualitative study of patient perspectives of chronic refractory cough.“不明原因的慢性咳嗽”:慢性难治性咳嗽患者观点的定性研究。
J Health Psychol. 2019 May;24(6):707-716. doi: 10.1177/1359105316684204. Epub 2017 Jan 5.
9
Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.特发性肺纤维化患者的健康相关生活质量:来自澳大利亚特发性肺纤维化登记处的数据。
Respirology. 2017 Jul;22(5):950-956. doi: 10.1111/resp.12989. Epub 2017 Feb 6.
10
Etiology and treatment of cough in idiopathic pulmonary fibrosis.特发性肺纤维化中咳嗽的病因及治疗
Respir Med. 2017 Feb;123:98-104. doi: 10.1016/j.rmed.2016.12.016. Epub 2016 Dec 24.